AlphAIalphai — Financial news for AI agents
investing.comAUG 253 min read$RUM

RUM, SLS, and ADMA: three undercovered mid-cap picks

Investing.com highlights three mid-cap stocks with low analyst coverage: Rumble (RUM) signed a $13.7B GPU deal, Sellas Life Sciences (SLS) rose 683% in a year, and ADMA Biologics (ADMA) trades at 13.7x earnings after a 44% pullback. RUM's Q2 revenue was $40.4M, up 61% YoY, with Q3 guidance of $87-93M. SLS has a 'Great' health score, while ADMA is profitable and shows early signs of stabilization.

Original reporting
investing.com
Published Aug 25, 2026, 2:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 2:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefTechnology
Primary signal
$RUM
Bullish
high confidence
Mentioned
$RUM · $SLS · $ADMA
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$RUMBullishHigh
01

Why it matters

The article surfaces a material contract for Rumble and underscores valuation anomalies in SLS and ADMA.

02

Market read

The GPU contract could re‑rate Rumble, while SLS and ADMA present speculative and value plays respectively.

03

What to watch

Liquidity constraints and limited analyst coverage may cause higher volatility for all three mids.

Relevance 8/10Novelty 8/10Timing: recently announced contract

Background

Mid‑cap stocks with low analyst coverage are being highlighted as potential hidden opportunities.

Company-level read

Ticker impact

$RUMBullishHigh confidence
Context

Rumble announced a $13.7 billion six‑year GPU services contract, its largest deal to date.

Expected impact

Potential upside as investors re‑price the AI‑compute exposure.

Evidence & confidence

Deal size and forward‑revenue guidance suggest a multi‑digit revenue run‑rate, which is material for a $3.7 B market‑cap stock.

$SLSNeutralMedium confidence
Context

Sellas Life Sciences posted a 683% YTD gain and a "Great" health rating, highlighting strong momentum.

Expected impact

Continued upside if clinical milestones are confirmed; sharp pull‑back possible on setbacks.

Evidence & confidence

Price move is driven by speculation rather than a concrete new catalyst.

$ADMABullishMedium confidence
Context

ADMA Biologics trades at a 13.7× P/E after a 44% pullback, positioning it as a rare profitable biotech.

Expected impact

Modest upside if earnings remain stable and market sentiment improves.

Evidence & confidence

Profitability at a discount is notable, but no new event drives the price.

Market effects

Sector

Highlights undervaluation of AI‑compute providers and may lift peers like CoreWeave.

Regional

U.S. AI infrastructure sector gains visibility.

Global

Large GPU contract underscores growing demand for AI compute worldwide.

Counterpoint

What could challenge this read

Rumble's valuation could be overstated if the GPU contract faces execution risk.

Key entities

  • company
    Rumble

    Video platform transitioning to AI compute services.

  • company
    Sellas Life Sciences

    Clinical‑stage biotech with strong price momentum.

  • company
    ADMA Biologics

    Profitable plasma‑derived therapeutics firm.

Read at source← All news

Related articles

AUG 25
$RUMMedAI 9/10

RUM Group signs six-year $13.7bn GPU services contract

RUM Group (formerly Rumble) signed a $13.7bn, six-year GPU services contract with an unnamed US cloud provider. The deal includes potential warrants for 50.81 million shares. RUM Group lacks financing for the contract and faces execution risks, according to SEC filings.

yahoo.com2 min
AUG 25
$RUMMedAI 8/10

Company Powering Truth Social Lands $13,700,000,000 American AI Deal

RUM Group Inc. (formerly Rumble Inc.) secured a $13.7 billion AI infrastructure deal with an undisclosed customer for a Georgia data center. The company lacks financing for the project but remains obligated under the agreement. The customer will receive cloud GPU services and the option to buy 51 million shares at $0.01 per share. Tether, RUM's largest shareholder, previously invested $775 million in the company.

dailycaller.com2 min
AUG 24
$RUMHighAI 9/10

RUM Group faces 12.7% dilution challenge in $13.7 billion AI transaction

RUM Group agreed to a $13.7B GPU services contract over six years, with a customer warrant for 12.7% of shares at $0.01 each. The deal requires significant new funding, and shares rose 5.5% on the news. RUM had $203.3M in cash and $66.1M in operating expenses for H1 2026. Analysts' views are limited, with risks including dilution, financing costs, and delivery delays.

ts2.tech2 min
AUG 24
$RUMHighAI 9/10

RUM Group (RUM) Shares Skyrocket, What You Need To Know

RUM Group's shares rose 6% after announcing a $13.7B contract with a U.S. cloud customer for AI chips and GPU services. The deal includes warrants for 50.8M Class A shares. RUM plans to seek financing to fulfill the contract. Q2 revenue was $40.37M, up 60.9% YoY, but GAAP loss per share widened to $0.28.

financialcontent.com2 min